COVID treatment via Plasma therapy: ICMR gives nod to GMC Amritsar

Punjab Medical Education and Research Minister O P Soni said that the patients infected with coronavirus would be soon treated with the plasma therapy in the Government Medical College (GMC).

Published On 2020-06-20 04:30 GMT   |   Update On 2020-06-20 04:30 GMT

Chandigarh - The Indian Council of Medical Research (ICMR) has given approval to the Government Medical College Amritsar to treat the patients of COVID-19 with plasma therapy. Stating this here on Friday, Punjab Medical Education and Research Minister O P Soni said that the patients infected with coronavirus would be soon treated with the plasma therapy in the Government Medical...

Login or Register to read the full article

Chandigarh -  The Indian Council of Medical Research (ICMR) has given approval to the Government Medical College Amritsar to treat the patients of COVID-19 with plasma therapy.

Stating this here on Friday, Punjab Medical Education and Research Minister O P Soni said that the patients infected with coronavirus would be soon treated with the plasma therapy in the Government Medical College (GMC).

Read Also: COVID-19 positive RML Dean undergoes plasma therapy in Delhi

Giving details, he said that all the requisite preparedness had already been completed to start this therapy within next few days.

Read Also:  Move ICMR on potential COVID-19 curing drug: Madras HC directs doctor


Tags:    
Article Source : UNI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News